(Q42538256)

1 November 2017

Effects of dipyridamole and inhaled nitric oxide in pediatric patients with pulmonary hypertension (English)

1 reference

1 November 2017

J W Ziegler

1

1 reference

1 November 2017

D D Ivy

2

1 reference

1 November 2017

J W Wiggins

3

1 reference

1 November 2017

J P Kinsella

4

1 reference

1 November 2017

W R Clarke

5

1 reference

1 November 2017

S H Abman

6

1 reference

1 November 2017

language of work or name

English

0 references

publication date

1 November 1998

1 reference

American Journal of Respiratory and Critical Care Medicine

1 November 2017

1 reference

1 November 2017

158

1 reference

1 November 2017

1388-1395

1 reference

1 November 2017

5 Pt 1

1 reference

Biological actions and properties of endothelium-derived nitric oxide formed and released from artery and vein

1 November 2017

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.158.5.9710117

Nitric oxide activates guanylate cyclase and increases guanosine 3′:5′-cyclic monophosphate levels in various tissue preparations

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.158.5.9710117

Evidence that cyclic guanosine monophosphate (cGMP) mediates endothelium-dependent relaxation

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.158.5.9710117

Primary sequence of cyclic nucleotide phosphodiesterase isozymes and the design of selective inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.158.5.9710117

Reduced expression of endothelial nitric oxide synthase in the lungs of patients with pulmonary hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.158.5.9710117

Inhibition of cyclic 3'-5'-guanosine monophosphate-specific phosphodiesterase selectively vasodilates the pulmonary circulation in chronically hypoxic rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.158.5.9710117

Inhaled nitric oxide. A selective pulmonary vasodilator reversing hypoxic pulmonary vasoconstriction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.158.5.9710117

Inhaled nitric oxide reverses pulmonary vasoconstriction in the hypoxic and acidotic newborn lamb.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.158.5.9710117

Inhaled nitric oxide in persistent pulmonary hypertension of the newborn

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.158.5.9710117

Inhaled nitric oxide in congenital heart disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.158.5.9710117

Use of inhaled nitric oxide and acetylcholine in the evaluation of pulmonary hypertension and endothelial function after cardiopulmonary bypass.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.158.5.9710117

The cGMP phosphodiesterase inhibitor zaprinast enhances the effect of nitric oxide.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.158.5.9710117

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.158.5.9710117

Hypoxic pulmonary hypertension: its modification by dipyridamole.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.158.5.9710117

Dipyridamole potentiates pulmonary vasodilation induced by acetylcholine and nitric oxide in the ovine fetus

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.158.5.9710117

Coronary angiography of Kawasaki disease with the coronary vasodilator dipyridamole: assessment of distensibility of affected coronary arterial wall.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.158.5.9710117

Hemodynamic effects of inhaled nitric oxide in heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.158.5.9710117

Dipyridamole attenuates rebound pulmonary hypertension after inhaled nitric oxide withdrawal in postoperative congenital heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.158.5.9710117

Anoxia and human pulmonary vascular resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.158.5.9710117

Increased lung vasoreactivity in children from Leadville, Colorado, after recovery from high-altitude pulmonary edema

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.158.5.9710117

Endothelium-dependent relaxation and cyclic GMP accumulation in rabbit pulmonary artery are selectively impaired by moderate hypoxia

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.158.5.9710117

Negative feedback regulation of endothelial cell function by nitric oxide

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.158.5.9710117

Inhaled nitric oxide leading to pulmonary edema in stable severe heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.158.5.9710117

10.1164/AJRCCM.158.5.9710117

21 January 2018

Identifiers

DOI

1 reference

1 November 2017

1 reference